{
    "info": {
        "nct_id": "NCT04742361",
        "official_title": "Phase III Study of [18F]PSMA-1007 Positron Emission Tomography for the Detection of Prostate Cancer Lesions in Patients With Biochemical Recurrence After Previous Definitive Treatment for Localized Prostate Cancer",
        "inclusion_criteria": "* Male with original diagnosis of adenocarcinoma of the prostate with prior definitive therapy\n* Suspicion of recurrence or persistence\n\n  * after radiotherapy or cryotherapy: 3 consecutive PSA rises and/or PSA rise by 2.0 ng/mL or more above nadir (ASTRO-Phoenix)\n  * after prostatectomy, PSA > 0.2 ng/mL on 2 or more determinations (recurrence), or failure of PSA to fall to undetectable levels post-prostatectomy (persistence) (American Urological Association)\n* For patients who previously had radical prostatectomy, salvage radiotherapy is one likely treatment plan; for patients who initially underwent radiotherapy (including brachytherapy), confirmation of low volume disease is needed to define (local) treatment.\n* Life expectancy of 6 months or more as judged by the investigator\n* Willing and able to undergo all study procedures\n* Informed consent in writing\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
        "exclusion_criteria": "* Age: less than18 years\n* Contraindications to any of the ingredients of [18F]PSMA-1007\n* Close affiliation with the investigational site\n* At the time of enrolment into this study, participating in another therapeutic clinical trial or has completed study participation in another therapeutic clinical trial within 5 days of enrolment into this trial\n* Having been previously enrolled in this clinical trial\n* Mental conditions rendering the subject incapable to understand the nature, scope, and consequences of the trial\n* Being clinically unstable or requiring emergency treatment\n* Patients who are unwilling to consider a biopsy if clinically recommended\n* Patients who are unable to undergo a PET/CT scan\n* Patients for whom systemic therapy is the most likely course regardless of PET findings.",
        "miscellaneous_criteria": ""
    },
    "inclusion_lines": [
        {
            "line": "Must have minimum age of 18 Years",
            "criterions": [
                {
                    "exact_snippets": "minimum age of 18 Years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "minimum",
                            "expected_value": {
                                "operator": ">=",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Life expectancy of 6 months or more as judged by the investigator",
            "criterions": [
                {
                    "exact_snippets": "Life expectancy of 6 months or more",
                    "criterion": "life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "duration",
                            "expected_value": {
                                "operator": ">=",
                                "value": 6,
                                "unit": "months"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "as judged by the investigator",
                    "criterion": "investigator judgment of life expectancy",
                    "requirements": [
                        {
                            "requirement_type": "assessment",
                            "expected_value": "investigator judgment"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* For patients who previously had radical prostatectomy, salvage radiotherapy is one likely treatment plan; for patients who initially underwent radiotherapy (including brachytherapy), confirmation of low volume disease is needed to define (local) treatment.",
            "criterions": [
                {
                    "exact_snippets": "patients who previously had radical prostatectomy",
                    "criterion": "history of radical prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "patients who initially underwent radiotherapy (including brachytherapy)",
                    "criterion": "history of radiotherapy (including brachytherapy)",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "confirmation of low volume disease is needed",
                    "criterion": "low volume disease",
                    "requirements": [
                        {
                            "requirement_type": "confirmation",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Informed consent in writing",
            "criterions": [
                {
                    "exact_snippets": "Informed consent in writing",
                    "criterion": "informed consent",
                    "requirements": [
                        {
                            "requirement_type": "documentation",
                            "expected_value": "in writing"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Male with original diagnosis of adenocarcinoma of the prostate with prior definitive therapy",
            "criterions": [
                {
                    "exact_snippets": "Male",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                },
                {
                    "exact_snippets": "original diagnosis of adenocarcinoma of the prostate",
                    "criterion": "prostate adenocarcinoma diagnosis",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": true
                        },
                        {
                            "requirement_type": "original diagnosis",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "prior definitive therapy",
                    "criterion": "definitive therapy",
                    "requirements": [
                        {
                            "requirement_type": "prior therapy",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* after prostatectomy, PSA > 0.2 ng/mL on 2 or more determinations (recurrence), or failure of PSA to fall to undetectable levels post-prostatectomy (persistence) (American Urological Association)",
            "criterions": [
                {
                    "exact_snippets": "after prostatectomy",
                    "criterion": "history of prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "PSA > 0.2 ng/mL on 2 or more determinations (recurrence)",
                    "criterion": "PSA level",
                    "requirements": [
                        {
                            "requirement_type": "quantity",
                            "expected_value": {
                                "operator": ">",
                                "value": 0.2,
                                "unit": "ng/mL"
                            }
                        },
                        {
                            "requirement_type": "number of determinations",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2,
                                "unit": "determinations"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "failure of PSA to fall to undetectable levels post-prostatectomy (persistence)",
                    "criterion": "PSA level post-prostatectomy",
                    "requirements": [
                        {
                            "requirement_type": "detectability",
                            "expected_value": "detectable"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* after radiotherapy or cryotherapy: 3 consecutive PSA rises and/or PSA rise by 2.0 ng/mL or more above nadir (ASTRO-Phoenix)",
            "criterions": [
                {
                    "exact_snippets": "after radiotherapy or cryotherapy",
                    "criterion": "prior treatment",
                    "requirements": [
                        {
                            "requirement_type": "treatment type",
                            "expected_value": [
                                "radiotherapy",
                                "cryotherapy"
                            ]
                        }
                    ]
                },
                {
                    "exact_snippets": "3 consecutive PSA rises",
                    "criterion": "PSA level",
                    "requirements": [
                        {
                            "requirement_type": "consecutive rises",
                            "expected_value": {
                                "operator": ">=",
                                "value": 3,
                                "unit": "consecutive rises"
                            }
                        }
                    ]
                },
                {
                    "exact_snippets": "PSA rise by 2.0 ng/mL or more above nadir",
                    "criterion": "PSA level",
                    "requirements": [
                        {
                            "requirement_type": "increase above nadir",
                            "expected_value": {
                                "operator": ">=",
                                "value": 2.0,
                                "unit": "ng/mL"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Suspicion of recurrence or persistence",
            "criterions": [
                {
                    "exact_snippets": "Suspicion of recurrence",
                    "criterion": "recurrence",
                    "requirements": [
                        {
                            "requirement_type": "suspicion",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Suspicion of ... persistence",
                    "criterion": "persistence",
                    "requirements": [
                        {
                            "requirement_type": "suspicion",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Healthy volunteers allowed",
            "criterions": [
                {
                    "exact_snippets": "Healthy volunteers allowed",
                    "criterion": "healthy volunteer status",
                    "requirements": [
                        {
                            "requirement_type": "eligibility",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Willing and able to undergo all study procedures",
            "criterions": [
                {
                    "exact_snippets": "Willing and able to undergo all study procedures",
                    "criterion": "willingness to undergo study procedures",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                },
                {
                    "exact_snippets": "Willing and able to undergo all study procedures",
                    "criterion": "ability to undergo study procedures",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "Must be MALE",
            "criterions": [
                {
                    "exact_snippets": "Must be MALE",
                    "criterion": "sex",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": "male"
                        }
                    ]
                }
            ]
        }
    ],
    "exclusion_lines": [
        {
            "line": "* Contraindications to any of the ingredients of [18F]PSMA-1007",
            "criterions": [
                {
                    "exact_snippets": "Contraindications to any of the ingredients of [18F]PSMA-1007",
                    "criterion": "contraindications to ingredients of [18F]PSMA-1007",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients who are unable to undergo a PET/CT scan",
            "criterions": [
                {
                    "exact_snippets": "Patients who are unable to undergo a PET/CT scan",
                    "criterion": "ability to undergo PET/CT scan",
                    "requirements": [
                        {
                            "requirement_type": "ability",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients for whom systemic therapy is the most likely course regardless of PET findings.",
            "criterions": [
                {
                    "exact_snippets": "Patients for whom systemic therapy is the most likely course regardless of PET findings.",
                    "criterion": "likelihood of systemic therapy",
                    "requirements": [
                        {
                            "requirement_type": "likelihood",
                            "expected_value": "systemic therapy is the most likely course"
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Mental conditions rendering the subject incapable to understand the nature, scope, and consequences of the trial",
            "criterions": [
                {
                    "exact_snippets": "Mental conditions rendering the subject incapable to understand the nature, scope, and consequences of the trial",
                    "criterion": "mental condition",
                    "requirements": [
                        {
                            "requirement_type": "capacity to understand trial",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Being clinically unstable or requiring emergency treatment",
            "criterions": [
                {
                    "exact_snippets": "Being clinically unstable",
                    "criterion": "clinical stability",
                    "requirements": [
                        {
                            "requirement_type": "status",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "requiring emergency treatment",
                    "criterion": "emergency treatment requirement",
                    "requirements": [
                        {
                            "requirement_type": "requirement",
                            "expected_value": false
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Having been previously enrolled in this clinical trial",
            "criterions": [
                {
                    "exact_snippets": "Having been previously enrolled in this clinical trial",
                    "criterion": "prior enrollment in this clinical trial",
                    "requirements": [
                        {
                            "requirement_type": "history",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* At the time of enrolment into this study, participating in another therapeutic clinical trial or has completed study participation in another therapeutic clinical trial within 5 days of enrolment into this trial",
            "criterions": [
                {
                    "exact_snippets": "At the time of enrolment into this study, participating in another therapeutic clinical trial",
                    "criterion": "participation in another therapeutic clinical trial",
                    "requirements": [
                        {
                            "requirement_type": "presence",
                            "expected_value": false
                        }
                    ]
                },
                {
                    "exact_snippets": "has completed study participation in another therapeutic clinical trial within 5 days of enrolment into this trial",
                    "criterion": "completion of another therapeutic clinical trial",
                    "requirements": [
                        {
                            "requirement_type": "time since completion",
                            "expected_value": {
                                "operator": "<=",
                                "value": 5,
                                "unit": "days"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Patients who are unwilling to consider a biopsy if clinically recommended",
            "criterions": [
                {
                    "exact_snippets": "Patients who are unwilling to consider a biopsy if clinically recommended",
                    "criterion": "willingness to consider biopsy",
                    "requirements": [
                        {
                            "requirement_type": "willingness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Age: less than18 years",
            "criterions": [
                {
                    "exact_snippets": "Age: less than18 years",
                    "criterion": "age",
                    "requirements": [
                        {
                            "requirement_type": "value",
                            "expected_value": {
                                "operator": "<",
                                "value": 18,
                                "unit": "years"
                            }
                        }
                    ]
                }
            ]
        },
        {
            "line": "* Close affiliation with the investigational site",
            "criterions": [
                {
                    "exact_snippets": "Close affiliation with the investigational site",
                    "criterion": "affiliation with the investigational site",
                    "requirements": [
                        {
                            "requirement_type": "closeness",
                            "expected_value": true
                        }
                    ]
                }
            ]
        }
    ],
    "miscellaneous_lines": [],
    "failed_inclusion": [],
    "failed_exclusion": [],
    "failed_miscellaneous": []
}